4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000042
CEO bought 59,700 shares at an average $0.02 ($921)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-10 | Purchase : show line 1 in the form | +5,000 | $0.02 | $79 | 24,708,097 | D |
| 2019-07-10 | Purchase : show line 2 in the form | +2,000 | $0.02 | $31 | 24,710,097 | D |
| 2019-07-10 | Purchase : show line 3 in the form | +20,000 | $0.02 | $310 | 24,730,097 | D |
| 2019-07-10 | Purchase : show line 4 in the form | +15,000 | $0.02 | $228 | 24,745,097 | D |
| 2019-07-10 | Purchase : show line 5 in the form | +5,000 | $0.02 | $76 | 24,750,097 | D |
| 2019-07-10 | Purchase : show line 6 in the form | +5,000 | $0.02 | $78 | 24,755,097 | D |
| 2019-07-10 | Purchase : show line 7 in the form | +2,000 | $0.02 | $30 | 24,757,097 | D |
| 2019-07-10 | Purchase : show line 8 in the form | +5,000 | $0.02 | $79 | 24,762,097 | D |
| 2019-07-11 | Purchase : show line 9 in the form | +500 | $0.02 | $8 | 24,762,597 | D |
| 2019-07-11 | Purchase : show line 10 in the form | +200 | $0.02 | $3 | 24,762,797 | D |
| Open-market purchases · 59,700 sh · avg $0.02 · $921 | ||||||
Loading xslF345X03/primary_doc.xml…